COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

about

Assessing Decline: Visualising Progression in Huntington's Disease using a Clinical Dashboard with Enroll-HD Data.

P2860

Q36383240-22533D82-1324-47B4-9B0F-C66470652E2A

P2860

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

Item

http://www.wikidata.org/entity/Q36140827

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

@ast

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

@en

type

Item

label

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

@ast

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

@en

prefLabel

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

@ast

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

@en

P1476

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

@en

P2093

Amandine Rialland

http://www.w3.org/2001/XMLSchema#string

Bertrand Fontaine

http://www.w3.org/2001/XMLSchema#string

Catherine Schramm

http://www.w3.org/2001/XMLSchema#string

Christophe Verny

http://www.w3.org/2001/XMLSchema#string

Cyril Goizet

http://www.w3.org/2001/XMLSchema#string

David Schmitz

http://www.w3.org/2001/XMLSchema#string

Emmanuel Dupoux

http://www.w3.org/2001/XMLSchema#string

French Speaking Huntington Group

http://www.w3.org/2001/XMLSchema#string

Isabelle Rebeix

http://www.w3.org/2001/XMLSchema#string

Katia Youssov

http://www.w3.org/2001/XMLSchema#string

P2860

Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain

Neurogenetics and pharmacology of learning, motivation, and cognition

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review

Random-effects models for longitudinal data

Intraclass correlations: uses in assessing rater reliability

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.

Analysis of multivariate mixed longitudinal data: a flexible latent process approach.

P304

e0161106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0161106

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexis Brice

Laurent Cleret de Langavant

Anne-Catherine Bachoud-Lévi

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27657697

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5033325

http://www.w3.org/2001/XMLSchema#string

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

about

P2860

P2860

COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932